Abstract
N-Acetylnorloline synthase (LolO) is one of several iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenases that catalyze sequential reactions of different types in the biosynthesis of valuable natural products. LolO hydroxylates C2 of 1-exo-acetamidopyrrolizidine before coupling the C2-bonded oxygen to C7 to form the tricyclic loline core. Each reaction requires cleavage of a C-H bond by an oxoiron(IV) (ferryl) intermediate; however, different carbons are targeted, and the carbon radicals have different fates. Prior studies indicated that the substrate-cofactor disposition (SCD) controls the site of H· abstraction and can affect the reaction outcome. These indications led us to determine whether a change in SCD from the first to the second LolO reaction might contribute to the observed reactivity switch. Whereas the single ferryl complex in the C2 hydroxylation reaction was previously shown to have typical Mössbauer parameters, one of two ferryl complexes to accumulate during the oxacyclization reaction has the highest isomer shift seen to date for such a complex and abstracts H· from C7 ∼ 20 times faster than does the first ferryl complex in its previously reported off-pathway hydroxylation of C7. The detectable hydroxylation of C7 in competition with cyclization by the second ferryl complex is not enhanced in 2H2O solvent, suggesting that the C2 hydroxyl is deprotonated prior to C7-H cleavage. These observations are consistent with the coordination of the C2 oxygen to the ferryl complex, which may reorient its oxo ligand, the substrate, or both to positions more favorable for C7-H cleavage and oxacyclization.
Original language | English |
---|---|
Pages (from-to) | 1674-1683 |
Number of pages | 10 |
Journal | Biochemistry |
Volume | 63 |
Issue number | 13 |
DOIs | |
State | Published - Jul 2 2024 |
Bibliographical note
Publisher Copyright:© 2024 American Chemical Society.
Funding
This work was supported by the National Institutes of Health (GM113106 to J.M.B., Jr., and C.K., GM118812 to J.M.B., Jr., and GM127079 to C.K.). C.-Y.L. was supported by a grant from the Jane Coffin Childs Memorial Fund for Medical Research.
Funders | Funder number |
---|---|
Jane Coffin Childs Memorial Fund for Medical Research | |
National Institutes of Health (NIH) | GM113106, GM127079, GM118812 |
National Institutes of Health (NIH) |
ASJC Scopus subject areas
- Biochemistry